NCT03418545 - A Safety and Effectiveness of VOLBELLA XC Hyaluronic Acid (HA) Injectable Gel to Correct Infraorbital Hollowing | Biotech Hunter

Enrollment

163

Participants

Timeline

Start Date

January 26, 2018

Primary Completion Date

October 17, 2018

Study Completion Date

August 22, 2019

Conditions

Infraorbital Hollowing

Interventions

DEVICE

JUVÉDERM VOLBELLA® XC injectable gel

JUVÉDERM® VOLBELLA™ XC dermal filler injected into the infraorbital and adjacent area.

Trial Locations (15)

Williams Plastic Surgery Specialists, Latham

Aesthetic Solutions, PA., Chapel Hill

Duke Aesthetic Center, Durham

Steven Fagien M.D.F.A.C.S., Boca Raton

Center For Sight, Sarasota

Brian Biesman, MD, Nashville

Lupo Center for Aesthetic and General Dermatology, New Orleans

The Center for Skin Research, Houston

Precision Dermatology, Bellaire

Christopher I. Zoumalan MD Inc., Beverly Hills

Cosmetic Laser Dermatology, San Diego

Facesplus, Inc., San Diego

Art of Skin MD, Solana Beach

Steve Yoelin MD Medical Associate, Inc., Newport Beach

Image Dermatology, P.C., Montclair